GLYAT and kidney cancer: Notably, the cumulative survival probability of patients affected by the investigated kidney cancers as a function of AAC expression levels, shows that the survival rate decreases with the decrease of AAC1 expression both in KIRC and KIRP affected patients and with the decrease of AAC2 expression in KIRC affected patients.